Keywords: biochem, pharma, receives, patent, lamivudine, announced, received

BioChem Pharma Receives Patent For Lamivudine

Article | 15 July 1996

Print This

- BioChem Pharma has announced that it has received a US protection patent covering its once-daily, oral treatment lamivudine for chronic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in